nifedipine has been researched along with Non-alcoholic Fatty Liver Disease in 3 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the effects of perindopril or barnidipine alone or combined with simvastatin on metabolic parameters and hepatic steatosis degree." | 2.80 | Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients. ( D'Angelo, A; Derosa, G; Maffioli, P; Mugellini, A; Pesce, RM, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, S | 1 |
| Han, D | 1 |
| Kang, HG | 1 |
| Jeong, SJ | 1 |
| Jo, JE | 1 |
| Shin, J | 1 |
| Kim, DK | 1 |
| Park, HW | 1 |
| Derosa, G | 1 |
| Mugellini, A | 1 |
| Pesce, RM | 1 |
| D'Angelo, A | 1 |
| Maffioli, P | 1 |
| Nakagami, H | 1 |
| Shimamura, M | 1 |
| Miyake, T | 1 |
| Shimosato, T | 1 |
| Minobe, N | 1 |
| Moritani, T | 1 |
| Kiomy Osako, M | 1 |
| Nakagami, F | 1 |
| Koriyama, H | 1 |
| Kyutoku, M | 1 |
| Shimizu, H | 1 |
| Katsuya, T | 1 |
| Morishita, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Some Emerging Biomarkers of Cardiovascular Risk Stratification in Hypertensive Patients: a 5-years Follow-up[NCT02064218] | 0 participants | Observational | 2007-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nifedipine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Hum | 2015 |
2 other studies available for nifedipine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance.
Topics: Administration, Intravenous; Animals; Autophagy; Calcium Channel Blockers; Delayed-Action Preparatio | 2019 |
Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet.
Topics: Alanine Transaminase; Animals; Bezafibrate; Calcium Channel Blockers; Choline Deficiency; Diet; Dise | 2012 |